NCT02536183: A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid Tumors |
|
|
| Terminated | 1 | 2 | US | Magnetic resonance high intensity focused ultrasound, MR-HIFU, Lyso-thermosensitive liposomal doxorubicin, LTLD; ThermoDox | AeRang Kim | Pediatric Cancer, Solid Tumors, Rhabdomyosarcoma, Ewing Sarcoma, Soft Tissue Sarcomas, Osteosarcoma, Neuroblastoma, Wilms Tumor, Hepatic Tumor, Germ Cell Tumors | 10/22 | 10/22 | | |
